Fig. 6From: Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treatChanges from baseline in SGRQ total and domain scores (A) and UCSD-SOBQ score (B) at week 52 in subgroups by changes in FVC % predicted at week 52 in the INPULSIS trials [40]. SGRQ, St George’s Respiratory Questionnaire; UCSD-SOBQ, University of California San Diego Shortness of Breath Questionnaire; FVC, forced vital capacityBack to article page